Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chondroitin sulfate + glucosamine + amino acids from sturgeons is a combination nutraceutical and dietary supplement containing chondroitin-6-sulfate, glucosamine, and amino acids extracted from sturgeon cartilage and tissues. The combination is intended to support joint health and potentially alleviate symptoms of osteoarthritis by promoting cartilage matrix synthesis and reducing inflammation. It was the subject of a scientific survey and feasibility study managed and funded by Stanislav Makarenko, a director associated with Asia Biotech Group (formerly ABG Pharma). However, it does not appear to be an active clinical pipeline asset for the company.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chondroitin sulfate + glucosamine + amino acids from sturgeons.